LITE vs REGN · P/E 153, rev $3.01B vs P/E 14, rev $14.34B
Lumentum Holdings Inc (LITE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Lumentum Holdings Inc (LITE) is a communication equipment company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LITE revenue for 2026-06-27 was $3.01B. Net income was -$6.94B. Revenue was up 83.2% from 2025-06-28 to 2026-06-27. LITE currently screens at market cap $67.72B and trailing P/E 153.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LITE currently screens at market cap $67.72B and trailing P/E 153.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LITE and REGN stock pages for the full models.
Not investment advice.